REDOX LIMITED (RDX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

RDX

RDX - REDOX LIMITED

FNArena Sector : Commercial Services & Supplies
Year End: June
GICS Industry Group : Capital Goods
Debt/EBITDA: 0.41
Index: ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$4.04

25 Jun
2026

0.020

OPEN

$4.03

0.50%

HIGH

$4.04

160,406

LOW

$3.99

TARGET
$3.667 -9.2% downside
Franking for last dividend paid out: 100%
OTHER COMPANIES IN THE SAME SECTOR
AIM . AL3 . ANN . ASB . CUP . DGL . IMB . KPG . SRV .
FNARENA'S MARKET CONSENSUS FORECASTS
RDX: 1
Title FY25
Actual		 FY26
Actual		 FY27
Forecast		 FY28
Forecast
EPS (cps) xxx 17.5 19.0 xxx
DPS (cps) xxx 13.0 13.3 xxx
EPS Growth xxx 19.2% 8.6% xxx
DPS Growth xxx 4.0% 2.3% xxx
PE Ratio xxx N/A 18.6 xxx
Dividend Yield xxx N/A 3.8% xxx
Div Pay Ratio(%) xxx 74.3% 70.0% xxx

Dividend yield today if purchased 3 years ago: 5.37%

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 3.68

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 25/08 - ex-div 6.50c (franking 100%)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202120222023202420252026
EPS Basic xxxxxxxxxxxxxxx17.5
DPS All xxxxxxxxxxxxxxx13.0
Sales/Revenue xxxxxxxxxxxxxxx1,330.2 M
Book Value Per Share xxxxxxxxxxxxxxx107.1
Net Operating Cash Flow xxxxxxxxxxxxxxx87.8 M
Net Profit Margin xxxxxxxxxxxxxxx6.91 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202120222023202420252026
Return on Capital Employed xxxxxxxxxxxxxxx16.61 %
Return on Invested Capital xxxxxxxxxxxxxxx15.94 %
Return on Assets xxxxxxxxxxxxxxx12.33 %
Return on Equity xxxxxxxxxxxxxxx16.61 %
Return on Total Capital xxxxxxxxxxxxxxx25.43 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx16.2 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202120222023202420252026
Short-Term Debt xxxxxxxxxxxxxxx26 M
Long Term Debt xxxxxxxxxxxxxxx19 M
Total Debt xxxxxxxxxxxxxxx45 M
Goodwill - Gross xxxxxxxxxxxxxxx-
Cash & Equivalents - Generic xxxxxxxxxxxxxxx123 M
Price To Book Value xxxxxxxxxxxxxxx3.71

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202120222023202420252026
Capex xxxxxxxxxxxxxxx3.4 M
Capex % of Sales xxxxxxxxxxxxxxx0.26 %
Cost of Goods Sold xxxxxxxxxxxxxxx1,032 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx145 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx0 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.8

No. Of Recommendations

3
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

UBS

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgan Stanley

22/02/2026

1

Overweight

$3.50

-13.37%

Redox is the next on Morgan Stanley's key ideas in small and mid-caps going into reporting season, with the analyst positive on the company's 1H26 earnings report, with scope for the result to beat expectations.

Consensus sales growth of around 6% for the half sits below the qualitative 1Q26 trading update, and there has been a pick up in domestic chemicals and ingredients import volumes over the first two months of 2Q26 from the prior quarter.

Management continue to remain cost disciplined, with scope for the share price to continue to re-rate.

Overweight. Target remains at $3.50. Industry view: In-Line.

FORECAST
Morgan Stanley forecasts a full year FY26 dividend of 10.40 cents and EPS of 15.90 cents.
Morgan Stanley forecasts a full year FY27 dividend of 11.40 cents and EPS of 17.50 cents.

Ord Minnett

xx/xx/xxxx

2

xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

0

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY
Access Extra Coverage Research History >

RDX STOCK CHART

FNArena News on RDX

Latest Commercial Services & Supplies News

1
TechnologyOne’s SaaS Transformation ‘Complete’

Oct 07 2025 - Australia
2
Is The Worst Now Over For Audinate?

Jun 09 2022 - Australia
3
Codan: The Benefit Of Diversification

May 26 2022 - Australia
4
Brambles: Worth Holding

May 17 2022 - Technicals
5
Too Low For Xero?

May 16 2022 - Australia
6
Eclipx Group Earnings Driving In The Fast Lane

May 11 2022 - Australia
7
The Dark Web: Australia’s Cyber Threat

May 09 2022 - Australia
8
Orora Packing a Punch With Growth Initiatives

May 04 2022 - Australia
9
Megaport Investors On Edge, Brokers Calm

Apr 27 2022 - Australia
10
Brambles In The Weeds Over Plastic Indecision

Apr 26 2022 - Australia